Hemostatic Management of Trauma-Induced Coagulopathy

Area of Science:

• Traumatology
• Hematology
• Critical Care Medicine

Background:

• Trauma-induced coagulopathy significantly contributes to mortality in trauma patients.
• Traditional resuscitation relied on crystalloids and packed red blood cells.
• Current massive transfusion protocols incorporate fresh frozen plasma and platelet ratios, limiting crystalloids.

Purpose of the Study:

• To outline current management strategies for trauma-induced coagulopathy.
• To highlight the role of hemostatic agents and goal-directed resuscitation.
• To emphasize the importance of critical care nurse knowledge in managing these complex cases.

Main Methods:

• Review of current massive transfusion protocols.
• Discussion of hemostatic agents: tranexamic acid, prothrombin complex concentrate, fibrinogen concentrate, recombinant activated factor VIIa.
• Emphasis on goal-directed resuscitation using viscoelastic tools for personalized therapy.

Main Results:

• Shift from traditional resuscitation to combination therapy with blood products.
• Introduction of specific hemostatic agents for refractory bleeding.
• Viscoelastic tools enable tailored component therapy, potentially reducing blood product use and thromboembolic risks.

Conclusions:

• Effective management of trauma-induced coagulopathy involves rapid diagnosis and appropriate hemostatic interventions.
• Goal-directed resuscitation with viscoelastic tools offers personalized treatment, potentially improving mortality and reducing complications.
• Critical care nurses require comprehensive knowledge of pathophysiology, diagnostics, and pharmacotherapeutics for optimal patient care.